Product Images Docetaxel
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 14 images provide visual information about the product associated with Docetaxel NDC 0955-1020 by Winthrop U.s, A Business Of Sanofi-aventis U.s. Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - docetaxel 01
Figure 1 - docetaxel 02
This appears to be a graph depicting Disease-Free Survival Probability (in percentage) over time (in months). The x-axis shows the time period in months, with data points every 6 months, and the y-axis shows the probability of survival without disease. The graph shows a probability of 100% at the first time point and decreases as time progresses. However, without additional information or context, it is difficult to determine the exact meaning or relevance of this graph.*
Figure 2 - docetaxel 03
This is a chart displaying the survival probability in percentage (%) over time in months. The survival probability starts at 100% and the chart shows the percentage at different intervals of 6 months up to 48 months.*
Figure 3 - docetaxel 04
This text appears to be a graph or chart related to the "Cumulative Probability" of "Overall Survival" over time in months. It also includes a statistical value of "Logrank p=0010". It is likely part of a larger report or study analyzing survival rates for a particular population or illness.*
Figure 4 - docetaxel 05
This is a graph showing cumulative probability vs survival time in months, with a range of 0 to 59 months. The graph is not fully shown in the given text, with only the axis labels visible.*
Figure 5 - docetaxel 06
It seems like a graph or chart representing survival probability based on survival time in months. However, without the accompanying graph or chart, it is difficult to provide further information.*
Figure 6 - docetaxel 07
Figure 7 - docetaxel 08
Figure 8 - docetaxel 09
This text is describing a graph or chart showing the probability of Progression Free Survival Time (months) over some period of time. The graph may be showing a 12-month duration, but it is unclear as the rest of the text is not available.*
Figure 9 - docetaxel 10
Survival probability data is provided, however, the numbers appear to be partially unreadable and don't make sense. The second line mentions "Survival Time" in months. It is unclear what this data relates to or what it represents.*
Figure 10 - docetaxel 11
PRINCIPAL DISPLAY PANEL - 4 mL Vial Carton - docetaxel 12
This is a description of a medication called Docetaxel. It is a ready to add to the infusion solution for intravenous use. The Docetaxel comes in a single-dose vial containing 20 mg/mL and is recommended to be discarded after use. It has a NOC number (0985102104) and is manufactured by Winthrop, a subsidiary of Sanofi. The other text is difficult to understand and lacks context.*
PRINCIPAL DISPLAY PANEL - 1 mL Vial Carton - docetaxel 13
This is a product label for Docetaxel injection manufactured by Winthrop for intravenous infusion only. Each vial contains a 20mg/mL solution to be used as a single-dose and any unused portion should be discarded. The product is intended for Rx-only use and the label has various identification numbers associated with it.*
PRINCIPAL DISPLAY PANEL - 8 mL Vial Carton - docetaxel 14
This is a medication label for a single-dose vial of Docetaxel Injection by Winthrop, with a strength of 150mg/gmL. It is intended for intravenous infusion only and the unused portion must be discarded. The label contains various codes and numbers, but there is no useful description.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.